争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 3 条
2022
佛罗里达州与CVS Health及制药公司达成阿片类药物和解
和解
佛罗里达州与CVS Health、Teva Pharmaceutical Industries、Allergan及Endo International达成总额超过8.78亿美元的和解，处理有关这些公司助长该州阿片类药物危机的指控。公司在同意和解时否认有不当行为。
当事方说明的目的. 解决相关索赔并避免下个月开庭审理。
品牌回应
否认 — CVS Health Corp, Teva Pharmaceutical Industries Ltd, Abbvie Inc's Allergan unit, and Endo International Plc
The four companies denied wrongdoing in agreeing to settle.
来源摘录
The four companies denied wrongdoing in agreeing to settle.
Florida has reached more than $878 million in settlements with CVS Health Corp and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic in the third most populous U.S. state.
2021
Allergan同意在纽约州阿片类药物诉讼和解中支付至多2亿美元
和解
Allergan同意就其在阿片类药物危机中的角色，向纽约州及拿骚县、萨福克县支付至多2亿美元以达成和解。诉讼称制造商和分销商淡化了成瘾风险；报道未提及法院对这些指控作出裁定。
来源摘录
Drug manufacturer Allergan has agreed to pay Suffolk and Nassau counties and the state of New York up to $200 million for its role in the opioid epidemic.
2018
阿片类药物相关诉讼
艾尔建与其他制药制造商和分销商一起，在美国各州和市政当局就阿片类药物流行提起的诉讼中被点名。诉讼涉及在阿片类药物的制造、营销或分销中的所谓角色；诉讼程序构成了更广泛的全国性阿片类药物诉讼的一部分。